Li-Shiun Chen1,2, Sarah M Hartz1, Timothy B Baker3, Yinjiao Ma1, Nancy L Saccone4, Laura J Bierut1,2. 1. Department of Psychiatry, Washington University School of Medicine, St Louis, MO 63110, USA. 2. Siteman Cancer Center, Washington University in St Louis, St Louis, MO 63110, USA. 3. Department of Medicine, University of Wisconsin School of Medicine & Public Health, Madison, WI 53711, USA. 4. Department of Genetics, Washington University School of Medicine, St Louis, MO 63110, USA.
Abstract
AIM: This study tests whether polygenic risk scores (PRSs) for nicotine metabolism predict smoking behaviors in independent data. MATERIALS & METHODS: Linear regression, logistic regression and survival analyses were used to analyze nicotine metabolism PRSs and nicotine metabolism, smoking quantity and smoking cessation. RESULTS: Nicotine metabolism PRSs based on two genome wide association studies (GWAS) meta-analyses significantly predicted nicotine metabolism biomarkers (R2 range: 9.2-16%; minimum p = 7.6 × 10-8). The GWAS top hit variant rs56113850 significantly predicted nicotine metabolism biomarkers (R2 range: 14-17%; minimum p = 4.4 × 10-8). There was insufficient evidence for these PRSs predicting smoking quantity and smoking cessation. CONCLUSION: Results suggest that nicotine metabolism PRSs based on GWAS meta-analyses predict an individual's nicotine metabolism, so does use of the top hit variant. We anticipate that PRSs will enter clinical medicine, but additional research is needed to develop a more comprehensive genetic score to predict smoking behaviors.
AIM: This study tests whether polygenic risk scores (PRSs) for nicotine metabolism predict smoking behaviors in independent data. MATERIALS & METHODS: Linear regression, logistic regression and survival analyses were used to analyze nicotine metabolism PRSs and nicotine metabolism, smoking quantity and smoking cessation. RESULTS:Nicotine metabolism PRSs based on two genome wide association studies (GWAS) meta-analyses significantly predicted nicotine metabolism biomarkers (R2 range: 9.2-16%; minimum p = 7.6 × 10-8). The GWAS top hit variant rs56113850 significantly predicted nicotine metabolism biomarkers (R2 range: 14-17%; minimum p = 4.4 × 10-8). There was insufficient evidence for these PRSs predicting smoking quantity and smoking cessation. CONCLUSION: Results suggest that nicotine metabolism PRSs based on GWAS meta-analyses predict an individual's nicotine metabolism, so does use of the top hit variant. We anticipate that PRSs will enter clinical medicine, but additional research is needed to develop a more comprehensive genetic score to predict smoking behaviors.
Authors: Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham Journal: Am J Hum Genet Date: 2007-07-25 Impact factor: 11.025
Authors: Megan E Piper; E Belle Federman; Danielle E McCarthy; Daniel M Bolt; Stevens S Smith; Michael C Fiore; Timothy B Baker Journal: Nicotine Tob Res Date: 2007-09 Impact factor: 4.244
Authors: F Patterson; R A Schnoll; E P Wileyto; A Pinto; L H Epstein; P G Shields; L W Hawk; R F Tyndale; N Benowitz; C Lerman Journal: Clin Pharmacol Ther Date: 2008-04-02 Impact factor: 6.875
Authors: Gary E Swan; Neal L Benowitz; Christina N Lessov; Peyton Jacob; Rachel F Tyndale; Kirk Wilhelmsen Journal: Pharmacogenet Genomics Date: 2005-02 Impact factor: 2.089
Authors: Michael Bray; Yoonhoo Chang; Timothy B Baker; Douglas Jorenby; Robert M Carney; Louis Fox; Giang Pham; Faith Stoneking; Nina Smock; Christopher I Amos; Laura Bierut; Li-Shiun Chen Journal: Nicotine Tob Res Date: 2022-10-17 Impact factor: 5.825
Authors: Alexander S Hatoum; Frank R Wendt; Marco Galimberti; Renato Polimanti; Benjamin Neale; Henry R Kranzler; Joel Gelernter; Howard J Edenberg; Arpana Agrawal Journal: Drug Alcohol Depend Date: 2021-10-09 Impact factor: 4.852
Authors: Victoria A Risner; Chelsie E Benca-Bachman; Lauren Bertin; Alicia K Smith; Jaakko Kaprio; John E McGeary; Elissa Chesler; Valerie S Knopik; Naomi P Friedman; Rohan H C Palmer Journal: Nicotine Tob Res Date: 2021-11-05 Impact factor: 4.244
Authors: Daniel L Hertz; Julie A Douglas; Kelley M Kidwell; Christina L Gersch; Zeruesenay Desta; Ana-Maria Storniolo; Vered Stearns; Todd C Skaar; Daniel F Hayes; N Lynn Henry; James M Rae Journal: Pharmacogenet Genomics Date: 2021-07-01 Impact factor: 2.000